Was Darktrace’s surge a case of sentiment-driven investing on steroids?
The AI firm’s journey so far shows nobody has a real idea of what cyber-fighting tech is worth Last modified on Wed 3 Nov 2021 15.56 EDT A loss-making business that uses artificial intelligence to spot cyber abnormalities was never likely to be easy to value but, even with that proviso, Darktrace’s first six months as a public company have […]
Read more